Journal Article

Differential metabolism of benzo[<i>a</i>]pyrene and benzo[<i>a</i>]pyrene-7,8-dihydrodiol by human CYP1A1 variants

Dieter Schwarz, Pyotr Kisselev, Ingolf Cascorbi, Wolf-Hagen Schunck and Ivar Roots

in Carcinogenesis

Volume 22, issue 3, pages 453-459
Published in print March 2001 | ISSN: 0143-3334
Published online March 2001 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/22.3.453
Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Cytochrome P450 1A1 (CYP1A1) plays a key role in the metabolism of carcinogens, such as benzo[a]pyrene (B[a]P) and metabolites to ultimate carcinogens. Three human allelic variants, namely wild-type (CYP1A1.1), CYP1A1.2 (I462V) and CYP1A1.4 (T461N), were coexpressed by coinfection of baculovirus-infected insect cells with human NADPH-P450 reductase. These recombinant enzymes (in microsomal membranes) were used to analyze whether CYP1A1 polymorphisms affect catalytic activities towards B[a]P and B[a]P-7,8-dihydrodiol. The complete spectrum of phase I metabolites, including the tetrahydrotetrols resulting from hydrolysis of the ultimate carcinogen, B[a]P-7,8-dihydrodiol-9,10-epoxide, was examined by HPLC. Wild-type enzyme showed the highest total metabolism of B[a]P, CYP1A1.2 was ~50%, and CYP1A1.4 ~70%. Km values for all metabolites with CYP1A1.2 were generally significantly lower than with wild-type enzyme (e.g. B[a]P-7,8-diol formation: 13.8 μM for wild-type, 3.5 μM for CYP1A1.2 and 7.7 μM for CYP1A1.4). Addition of epoxide hydrolase markedly increases the relative diol-to-phenol activities by all three variants. However, CYP1A1.4 exhibits the greatest efficiency to produce diol species. Each variant produced the diol epoxides from B[a]P-7,8-dihydrodiol. CYP1A1.1 exhibited with 10.4 pmol/min/pmol CYP1A1 the greatest total rate for 7,8-diol metabolites followed by CYP1A1.2 (7.2 pmol/min/pmol CYP1A1) and CYP1A1.4 (5.5 pmol/min/pmol CYP1A1). All enzyme variants produced about three times more diol epoxide 2-derived metabolites than diol epoxide 1-derived ones, whereby both rare allelic variants exhibited statistically significantly increased formation of diol epoxide 2. This study showed that the three CYP1A1 variants had different enzyme kinetics properties to produce both the diol metabolites from B[a]P and the ultimate mutagenic species diol epoxide 2 from B[a]P-7,8-dihydrodiol, which must be considered in the evaluation of individual susceptibility to cancer.

Keywords: B[a]P, benzo[a]pyrene; CYP, cytochrome P450; CYP1A1, cytochrome P450 1A1; DE1, (±)-B[a]P-r-7,t-8-dihydrodiol-c-9,10-epoxide; DE2, (±)-B[a]P-r-7,t-8-dihydrodiol-t-9,10-epoxide; 4,5-diol, B[a]P-trans-4,5-dihydrodiol; 7,8-diol, B[a]P-trans-7,8-dihydrodiol; 9,10-diol, B[a]P-trans-9,10-dihydrodiol; DMSO, dimethylsulfoxide; EH, epoxide hydrolase; EROD, 7-ethoxyresorufin O-deethylation; 3-OH, 3-hydroxybenzo[a]pyrene; 9-OH, 9-hydroxybenzo[a]pyrene; OR, human NADPH-P450 reductase; RTCC, (±)-B[a]P-r-7,t-8,c-9,c-10-tetrahydrotetrol; RTCT, (±)-B[a]P-r-7,t-8,c-9,t-10-tetrahydrotetrol; RTTC, (±)-B[a]P-r-7,t-8,t-9,c-10-tetrahydrotetrol; RTTT, (±)-B[a]P-r-7,t-8,t-9,t-10-tetrahydrotetrol; Sf9, Spodoptera frugiperda insect cell line.

Journal Article.  6310 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.